PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Bright X-ray flashes created in laser lab

At the Vienna University of Technology, a very special kind of bright coherent x-ray radiation has been created by an international team of scientists; the new method was presented in the current issue of Science

Bright X-ray flashes created in laser lab
2012-06-08
(Press-News.org) A breakthrough in laser science was achieved in Vienna: In the labs of the Photonics Institute at the Vienna University of Technology, a new method of producing bright laser pulses at x-ray energies was developed. The radiation covers a broad energy spectrum and can therefore be used for a wide range of applications, from materials science to medicine. Up until now, similar kinds of radiation could only be produced in particle accelerators (synchrotrons), but now a laser laboratory can also achieve this. The new laser technology was presented in the current issue of the magazine Science.

Laser Light: Photons Oscillating in Sync

In a laser beam, all the photons oscillate in perfect unison. The wave crests are aligned – this kind of radiation is called "coherent". The coherent light created in the labs of Professor Andrius Baltuska's team (Photonics Institute, TU Vienna) has very special properties: It is composed from photons of very different energies – extending to x-ray radiation with very short wavelengths and high energy.

Infrared Light Makes Atoms Emit X-Rays

The energy for this kind of radiation is supplied by short infrared laser pulses. They are fired at noble gas, where they rip electrons out of the atoms. These electrons are then accelerated by the infrared light and return to their atoms, where they convert their kinetic energy into x-ray radiation. That way, long-wave infrared photons are converted into short-wave x-ray photons. When the atoms in the gas container all do this dance with their electrons in the right rhythm and all the x-ray-waves add up perfectly, a beam of laser-like x-rays is created. Research groups from several universities were involved in this experiment: Vienna University of Technology, University of Colorado, Columbia University and the University of Salamanca.

5000 Photons Combined to One Single Photon

The idea of combining several photons to a single photon with higher energy is not new: In 1961, two photons from a red ruby laser were combined to one blue photon. The new experiment however combines more than 5000 photons of low energy to one high-energy x-ray photon.

The infrared photons have a rather low energy – but for the experiment, a large number of them is needed. That is why the infrared source has to be very strong. A unique infrared laser was used, specially developed at the Vienna University of Technology, with a peak power of 100 gigawatts. This corresponds to the power of several hundred hydroelectric power plants – but only during the short laser pulse, which lasts for femtoseconds (10^-15 seconds). The team from the University of Colorado contributed know-now on the creation of x-rays in noble gas at high pressure. The theory groups from Cornell and Salamanca studied the phenomenon using numerical calculations.

Working with Invisible Radiation

"Together we discussed how to combine the technological know how of our research teams, and finally we chose the most challenging path", says Audrius Pugzlys (TU Vienna). The team decided to use infrared radiation with a very long wavelength of four micrometers. This kind of radiation is invisible to the human eye and it is hard to trace even with technological tools. This makes the experiments very challenging, but it allows for higher x-ray energies. The effort finally paid off: "Our coherent x-ray radiation opens the door to very precise spectroscopy, which can be used to research new materials, to advance electronics or to analyze biomolecules", says Audrius Pugzlys.

Laser Labs Instead of Particle Accelerators

This kind of radiation used to be available only in expensive particle accelerators (synchrotrons). The new table top x-ray light source, however, can be assembled in a small laser lab. "Synchrotrons still deliver more photons per second than our beam does, but for many applications, our light source will be very useful", says Audrius Pugzlys. The hard x-ray regime of photons with extremely high energy cannot yet be reached, but the energy of the photons in the x-ray beam is much higher than in any other light-powered tabletop device. Now the team is trying to reduce the time interval between the laser pulses. This should drastically increase the average intensity of the beam.



INFORMATION:

Further Information:

Prof. Andrius Baltuska
Photonics Institute
Vienna University of Technology
Gusshausstraße 25-29, 1040 Vienna
T: +43-1-58801-38749
andrius.baltuska@tuwien.ac.at

Dr. Audrius Pugzlys
Photonics Institute
Vienna University of Technology
Gusshausstraße 25-29, 1040 Vienna
T: +43-1-58801-38720
audrius.pugzlys@tuwien.ac.at


[Attachments] See images for this press release:
Bright X-ray flashes created in laser lab

ELSE PRESS RELEASES FROM THIS DATE:

Newly identified protein function protects cells during injury

2012-06-08
CINCINNATI – Scientists have discovered a new function for a protein that protects cells during injury and could eventually translate into treatment for conditions ranging from cardiovascular disease to Alzheimer's. Researchers report online June 7 in the journal Cell that a type of protein called thrombospondin activates a protective pathway that prevents heart cell damage in mice undergoing simulated extreme hypertension, cardiac pressure overload and heart attack. "Our results suggest that medically this protein could be targeted as a way to help people with many ...

Report addresses challenges in implementing new diagnostic tests where they are needed most

2012-06-08
Easy-to-use, inexpensive tests to diagnose infectious diseases are urgently needed in resource-limited countries. A new report based on an American Academy of Microbiology colloquium, "Bringing the Lab to the Patient: Developing Point-of-Care Diagnostics for Resource Limited Settings," describes the challenges inherent in bringing new medical devices and technologies to the areas of the world where they are needed most. Point-of-care diagnostics (POCTs) bypass the need for sophisticated laboratory systems by leveraging new technologies to diagnose infectious diseases and ...

11 integrated health systems form largest private-sector diabetes registry in US

2012-06-08
(PORTLAND, Ore.) —June 07, 2012—Eleven integrated health systems, with more than 16 million members, have combined de-identified data from their electronic health records to form the largest, most comprehensive private-sector diabetes registry in the nation. According to a new study published today in the Centers for Disease Control and Prevention's Preventing Chronic Disease, the SUPREME-DM DataLink provides a unique and powerful resource to conduct population-based diabetes research and clinical trials. "The DataLink will allow us to compare more prevention and ...

U Alberta finds weakness in armor of killer hospital bacteria

2012-06-08
There's new hope for development of an antibiotic that can put down a lethal bacteria or superbug linked to the deaths of hundreds of hospital patients around the world. Researchers from the University of Alberta-based Alberta Glycomics Centre found a chink in the molecular armour of the pathogen Acinetobacter baumannii. The bacteria first appeared in the 1970's and in the last decade it developed a resistance to most antibiotics. U of A microbiologist Mario Feldman identified a mechanism that allows Acinetobacter baumannii to cover its surface with molecules knows ...

Personalizing biologic treatment to individual patients with rheuatoid arthritis is cost-effective

2012-06-08
Berlin, Germany, June 7 2012: Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tailoring biologic treatment to individual patients with rheumatoid arthritis (RA) can reduce total costs by €2,595,557 per 272 patients over 3 years (95 percentile range -€2,983,760 to -€2,211,755), whilst increasing effectiveness by an average of 3.67 quality-adjusted life years (QALYs)*. Cost savings were mostly on drug costs. The Dutch study, which investigated 272 patients with RA starting adalimumab treatment, measured ...

Treatment with anti-TNFs reduces the risk of cardiovascular events in rheumatoid arthritis

2012-06-08
Berlin, Germany, June 7 2012: Results from a retrospective analysis of contemporary data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, predict, based on estimates from a multivariate regression model, that the cumulative use of anti-tumour necrosis factor drugs (anti-TNFs) for one, two, or three years is associated with reduced risk of cardiovascular events by 24%, 42% and 56% in patients with rheumatoid arthritis (RA) respectively, compared to not using anti-TNF therapies (adjusting for background use of methotrexate or other ...

Nearly two-thirds of American osteoporotic hip fractures are seen in the extreme elderly

2012-06-08
Berlin, Germany, June 7 2012: A new American study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, calls for more aggressive management of osteoporosis in the extreme elderly as the true impact of osteoporotic hip fractures in those aged 80 years or older is unveiled. Via the Nationwide Inpatient Sample (NIS), 4.3 million patients over the age of 65 with osteoporotic hip fractures were studied. Results showed that 67.3% of hip fractures occurred in the extreme elderly, increasing from 172,209 in 1993 to 180,428 in 2008. This ...

Patients taking certolizumab pegol are twice as likely to achievE ACR20 compared to placebo

2012-06-08
Berlin, Germany, June 7 2012: A new Phase III study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that patients treated with certolizumab pegol (CZP) were twice as likely to meet the primary endpoint of ACR20* response at week 12 than those on placebo: 58% on CZP200mg Q2W; and 51.9% on CZP 400 mg Q4W compared to 24.3% on placebo. This randomised, placebo controlled, 24 week period of an ongoing Phase III study of 409 patients indicated that more patients treated with both doses of CZP achieved ACR50* and ACR70* response ...

Control of disease activity and biologic treatment increase life expectency in RA patients

2012-06-08
Berlin, Germany, June 7 2012: According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a significantly lower mortality risk (adjusted hazard ratio [HR]: 0.61) than those just treated with traditional disease modifying anti-rheumatic drugs (DMARDs).The study also found the mortality was similar irrespective of the method of action of biologics (anti-tumour necrosis factor drugs [anti-TNFs] or rituximab). Results of the German study ...

Treatment with anti-TNFs can increase the risk of shingles by up to 75 percent

2012-06-08
Berlin, Germany, June 7 2012: Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism. "Anti-TNFs, such as infliximab, adalimumab and etanercept have become the treatment of choice for patients with inflammatory rheumatic diseases who ...

LAST 30 PRESS RELEASES:

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

[Press-News.org] Bright X-ray flashes created in laser lab
At the Vienna University of Technology, a very special kind of bright coherent x-ray radiation has been created by an international team of scientists; the new method was presented in the current issue of Science